最近使用个人葡萄糖计作为生物传感器读取非葡萄糖目标的最新进展
Songbai Zhang1,2, Shuang Li1, Rixin Yan1
1Hunan Provincial Key Laboratory of Water Treatment Functional Materials, Hunan Province Engineering Research Center of Electroplating Wastewater Reuse Technology, Hunan Province Cooperative Innovation Center for The Construction & Development of Dongting Lake Ecological Economic Zone, College of Chemistry and Materials Engineering, Hunan University of Arts and Science, Changde 415000, P. R. China.
Current analytical chemistry
|October 9, 2023
概括
个人葡萄糖计 (PGM),最初用于血糖,现在检测各种非葡萄糖目标. 本综述探讨了先进的PGM,强调了用于更广泛的生物传感应用的新信号传导和放大方法.
科学领域:
- 生物医学工程 生物医学工程
- 分析化学 分析化学
- 生物传感器技术技术
背景情况:
- 个人血糖计 (PGM) 是非常成功的生物传感器,因为它们的便携性,易用性和可负担性.
- 最近的进展利用了PGM技术来检测超出血糖监测范围的各种非葡萄糖标.
研究的目的:
- 审查用于非葡萄糖分析物的基于PGM的生物传感器的最新进展.
- 讨论信号传导,放大策略和目标识别方法.
- 概述该领域当前的挑战和未来的前景.
主要方法:
- 关于用于非葡萄糖点的基于PGM的生物传感器的最新文献的审查.
- 分析各种信号传导机制 (例如酶).
- 检查信号放大技术 (例如,纳米材料,核酸反应).
主要成果:
- 可以调整PGM来检测不同的目标,包括金属离子,小分子,蛋白质,细菌和病原体.
- 像反转酶和氨酶这样的酶作为信号传导元素.
- 先进的放大方法,如纳米材料,DNAzymes,和生物素-streptavidin系统提高检测能力.
结论:
- PGM技术为开发各种非葡萄糖分析物的新型生物传感器提供了一个多功能平台.
- 多种信号传导和放大策略的整合扩大了PGM的应用范围.
- 持续的研究有望进一步创新基于PGM的生物传感用于诊断和环境监测.
相关概念视频
01:10Amperometry: Overview
583
Amperometry is a technique commonly used to measure the concentration of specific analytes in a solution by monitoring the electric current generated during an electrochemical reaction. It involves applying a constant potential between a working electrode and a reference electrode to measure the resulting current, which is proportional to the concentration of the analyte. The Clark oxygen electrode operates based on this principle of amperometry. It consists of a cathode and an anode enclosed...
583
01:15Hypoglycemia and Glucagon
277
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
277